Skip to Main Content

Author Details

Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
2016
77
16
PMIDPaper TitleJournal TitlePublished Year
37949350Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities.Transl Res2024
36928072The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers.PLoS One2023
38074678Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients.Front Oncol2023
37745365A clinicogenomic model including GARD predicts outcome for radiation treated patients with HPV+ oropharyngeal squamous cell carcinoma.medRxiv2023
37504352Radiation-Induced Oropharyngeal Squamous Cell Carcinoma: Case Report and Review of the Literature.Curr Oncol2023
37781187Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure.Front Oncol2023
37778228Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience.Oral Oncol2023
37680121NUT carcinoma of the submandibular gland: A case report.Cancer Rep (Hoboken)2023
37455307MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.Biomark Res2023
36974574Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC).Future Oncol2023
37004837Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset.Radiother Oncol2023
36798825A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol.Front Oncol2023
36733354HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients.Front Oncol2023
35083153Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report.Front Oncol2022
35675524Spondylodiscitis in Pediatric Age: A Retrospective Cohort Study.Pediatr Infect Dis J2022
36551656The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients.Cancers (Basel)2022
36442320Immune-based classification of HPV-associated oropharyngeal cancer with implications for biomarker-driven treatment de-intensification.EBioMedicine2022
36241485Which future for de-intensified treatments in HPV-related oropharyngeal carcinoma?Semin Oncol2022
36231138An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.Cells2022
33849307Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic.Tumori2022
35121395Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.Oral Oncol2022
32924878Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series.Tumori2021
36046116Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies.Explor Target Antitumor Ther2021
33844854Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysis.Int J Cancer2021
33857413Next generation platinum salt in nasopharygeal carcinoma.Lancet Oncol2021
33797698Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib.Endocrine2021
34917512Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review.Front Oncol2021
34994640An Old but Still Unanswered Question in Recurrent or Metastatic Salivary Duct Carcinoma.JCO Precis Oncol2021
34738049Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.JCO Precis Oncol2021
34439136Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients.Cancers (Basel)2021
34597119Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.J Clin Oncol2021
34506831Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma.Radiother Oncol2021
34680331Particle Beam Therapy Tolerance and Outcome on Patients with Autoimmune Diseases: A Single Institution Matched Case-Control Study.Cancers (Basel)2021
34298670A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study to Evaluate the Efficacy of Aqualief<sup>TM</sup> Mucoadhesive Tablets in Head and Neck Cancer Patients Who Developed Radiation-Induced Xerostomia.Cancers (Basel)2021
34210048A Prospectively Validated Prognostic Model for Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck Based on Radiomics of Computed Tomography Images.Cancers (Basel)2021
34117666Bleeding complications in patients with squamous cell carcinoma of the head and neck.Head Neck2021
33107152Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.Head Neck2021
33211282AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.Cell Oncol (Dordr)2021
32656672Management of loco-regionally advanced squamous laryngeal cancer in elderly patients.Eur Arch Otorhinolaryngol2021
31369156Locally advanced epithelial sinonasal tumors: The impact of multimodal approach.Laryngoscope2020
32031693Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life.Cancer2020
33327563Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era.Cancers (Basel)2020
33072562Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients.Front Oncol2020
33066161Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients.Cancers (Basel)2020
32629365Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands.Eur J Cancer2020
33018191Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients.Annu Int Conf IEEE Eng Med Biol Soc2020
32722718Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32442178Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.PLoS One2020
32497251Induction chemotherapy is the best timekeeper in nasopharyngeal carcinoma.Cancer2020
32454415Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet).Oral Oncol2020
  • 1 - 50 of 77

Recommended Authors

Damian T Rieke
German Cancer Consortium and German Cancer Research Center
Career Start Year 2015
Number of shared co-authors 0
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
Takahito Fukusumi
Osaka University Graduate School of Medicine
Career Start Year 2012
Number of shared co-authors 0
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 2
Alan L Ho
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 2
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Farhoud Faraji
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
Katharine A Price
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 4
Julie E Bauman
George Washington University
Career Start Year 2007
Number of shared co-authors 1
Bhumsuk Keam
Seoul National University Hospital
Career Start Year 2006
Number of shared co-authors 2
Hye Ryun Kim
Yonsei Cancer Center, Yonsei University College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 2
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 13
Luc G T Morris
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 14
Robert I Haddad
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2001
Number of shared co-authors 3
Ezra E W Cohen
university of california san diego Health System
Career Start Year 2001
Number of shared co-authors 2
Sana D Karam
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 1
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 0
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 2
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 3
Eric J Sherman
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 2
Patrick K Ha
University of California San Francisco
Career Start Year 1998
Number of shared co-authors 1
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 0
Lillian L Siu
Princess Margaret Cancer Centre, University Ave
Career Start Year 1995
Number of shared co-authors 3
Michael Allg??uer
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 3
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 2
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 2
David G Pfister
Memorial Sloan Kettering Cancer Center
Career Start Year 1987
Number of shared co-authors 1
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Lisa Licitra
Fondazione IRCCS Istituto Nazionale dei Tumori and University of Milan
Co-authored papers 56
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Co-authored papers 11
Tito Poli
University Hospital of Parma
Co-authored papers 9
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Co-authored papers 8
Charles R Leemans
Location Vrije Universiteit Amsterdam
Co-authored papers 7
Kathrin Scheckenbach
Heinrich-Heine University
Co-authored papers 7
Frank J P Hoebers
Maastricht University Medical Centre
Co-authored papers 7
Annalisa Trama
Fondazione IRCSS Istituto Nazionale dei Tumori
Co-authored papers 7
Ralph T H Leijenaar
Maastricht University Medical Center (MUMC+)
Co-authored papers 3
Philippe Lambin
Maastricht University
Co-authored papers 2
Giuseppe Fico
Universidad Politecnica de Madrid
Co-authored papers 2
Alice Dawson
University of Dundee
Co-authored papers 1
Shawn S-C Li
University of Western Ontario
Co-authored papers 1
Francisco Laxague
Schulich School of Medicine & Dentistry, Western University
Co-authored papers 1
Eitan Prisman
University of British Columbia
Co-authored papers 1
Catherine F Poh
University of British Columbia
Co-authored papers 1
Sarah E B Ryan
University of Western Ontario
Co-authored papers 1
Mushfiq H Shaikh
University of Western Ontario
Co-authored papers 1
Arnoldo Frigessi
University of Oslo
Co-authored papers 1
Christopher J Howlett
Western University
Co-authored papers 1
Mara S Serafini
Fondazione IRCCS Istituto Nazionale dei Tumouri
Co-authored papers 1
Vincenzo Rochira
University of Modena and Reggio Emilia
Co-authored papers 1
Sabrina Daniela da Silva
Jewish General Hospital
Co-authored papers 1
John W Barrett
University of Western Ontario
Co-authored papers 1
Mohammed I Khan
Stanford University
Co-authored papers 1
Matthew J Cecchini
Western University
Co-authored papers 1
Peter Y F Zeng
University of Western Ontario
Co-authored papers 1
Joseph C Dort
Cumming School of Medicine, University of Calgary
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Halema Khan
University of Western Ontario
Co-authored papers 1
Release 1.2